An estimated 18,000 people in the United States annually suffer from new injuries to their spinal cords. Unfortunately for ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

Cogent Biosciences, Inc.’s COGT share price has surged by 7.47%, which has investors questioning if this is right time to sell.

U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive ...

The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.

KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3 harboring an internal tandem duplication mutation; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...